Brandon Chambers
Nurse Practitioner · Jackson, MSNPI 1174020770
Payments from drug & device makers
Across 499 payments — averaging $23.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- Inspire Medical Systems, Inc.$2K
- AstraZeneca$1K
- Boehringer Ingelheim$961
- Actelion Pharmaceuticals US, Inc.$940
- 3b Medical, Inc.$930
- plus $3K from 25 others
What the payments were for
- Travel & lodging$1,49313%
- Food & beverage$10,02285%
- Education$2162%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 165 | $2,365 |
| Inspire Medical Systems, Inc. | 14 | $2,093 |
| AstraZeneca | 33 | $1,186 |
| Boehringer Ingelheim | 65 | $961 |
| Actelion Pharmaceuticals US, Inc. | 43 | $940 |
| 3b Medical, Inc. | 4 | $930 |
| Sanofi | 34 | $545 |
| Mylan Specialty L.p. | 22 | $393 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $373 |
| Regeneron Healthcare Solutions, Inc. | 16 | $329 |
| Bayer | 5 | $277 |
| Genentech USA, Inc. | 11 | $190 |
| Mallinckrodt Hospital Products Inc. | 9 | $170 |
| Electromed, Inc. | 11 | $149 |
| United Therapeutics Corporation | 8 | $143 |
| Johnson & Johnson | 9 | $128 |
| Insmed, Inc. | 7 | $103 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Merck | 4 | $66 |
| Baxter Healthcare | 3 | $47 |
| Pulmonx Corporation | 2 | $40 |
| Inari Medical, Inc. | 2 | $34 |
| AbbVie | 2 | $30 |
| Gilead | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Avanos Medical | 1 | $22 |
| Philips North America LLC | 1 | $20 |
| Ambu Inc. | 1 | $20 |
| Boston Scientific | 1 | $17 |
| Amgen | 1 | $14 |
| Advanced Respiratory, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,731 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 825 | $625,487 |
| OfevNintedanib Esylate | 26 | $338,949 |
| Dupixent PenDupilumab | 53 | $217,397 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 212 | $158,440 |
| EliquisApixaban | 202 | $138,823 |
| OpsumitMacitentan | 11 | $138,433 |
| Breo ElliptaFluticasone/Vilanterol | 270 | $126,164 |
| XareltoRivaroxaban | 114 | $84,798 |
| Spiriva RespimatTiotropium Bromide | 115 | $76,045 |
| NucalaMepolizumab | 20 | $71,822 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 124 | $60,116 |
| Dupixent SyringeDupilumab | 14 | $54,842 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 90 | $51,457 |
| SymbicortBudesonide/Formoterol Fumarate | 119 | $38,990 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 750 | $25,611 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Nucala, Anoro Ellipta, Incruse Ellipta | $2,365 | $896,6581,273 claims |
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat | $961 | $484,298258 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,186 | $212,538362 claims |
| Actelion Pharmaceuticals US, Inc.Opsumit | $940 | $138,43311 claims |
| Johnson & JohnsonXarelto | $128 | $84,798114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Jackson
- Catherine WellsJackson$75K
- Jo Anna WarrenJackson$73K
- Michelle TharpJackson$28K
- Jennifer HollyJackson$16K
- Ramona BallJackson$9K
- Bonney SimmonsJackson$9K
- Tamecia HerbertJackson$8K
- Amy HeidelbergJackson$7K
- Amy LemlyJackson$6K
- Jennifer PateJackson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.